The notices it replaced
- Reissues: PAR-13-358 Opportunities for Collaborative Research at the NIH Clinical Center (U01)
- 2 steps back: PAR-13-029 Opportunities for Collaborative Research at the NIH Clinical Center (U01)
Replaced by PAR-18-646.
Who won it before
30 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $14,174,868 in first-year total cost, median $468,083.
Most frequent study sections
- Special Emphasis Panel[ZRG1 BDCN-L (60)]7
- Special Emphasis Panel[ZHL1 CSR-S (O1)]4
- Special Emphasis Panel[ZAI1 BLG-M (S1)]3
- Special Emphasis Panel[ZCA1 SRLB-R (O1)]3
- Special Emphasis Panel[ZAI1 FDS-M (S1)]2
Most frequent institutions
- CHILDREN'S RESEARCH INSTITUTE3
- BRIGHAM AND WOMEN'S HOSPITAL2
- JOHNS HOPKINS UNIVERSITY2
- MASSACHUSETTS GENERAL HOSPITAL2
- UNIVERSITY OF ARIZONA2
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Protective Role of Nonclassical Monocytes in Immunotherapies for Solid Cancers1U01CA224766-01 | HEDRICK, CATHERINE CKAPLAN, ROSANDRASTRONCEK, DAVID FRANK | LA JOLLA INSTITUTE FOR IMMUNOLOGY, CA | $418,320 | ZCA1 |
| 2018 | Treatment of CGD with the PPAR-gamma agonist, pioglitazone, enhances phagocyte anti-inflammatory and antimicrobial responses1U01AI122269-01A1 | BRATTON, DONNA LHOLLAND, STEVEN M | NATIONAL JEWISH HEALTH, CO | $166,582 | ZAI1 |
| 2017 | Evaluation of the Safety and Efficacy of Angiotensin 1-7 to Enhance Cognitive Function in Participants Undergoing Coronary Artery Bypass Graft (CABG) Surgery1U01HL131014-01A1 | ARAI, ANDREW EHAY, MEREDITHRYAN, LEESWEITZER, NANCY K | UNIVERSITY OF ARIZONA, AZ | $745,065 | ZHL1 |
| 2017 | Immuno-Genetic Basis for Human Disseminated Coccidioidomycosis1U01AI122275-01A1 | GALGIANI, JOHN NHOLLAND, STEVEN MLUSSIER, YVES A | UNIVERSITY OF ARIZONA, AZ | $573,884 | ZAI1 |
| 2017 | Intravenous delivery of 2-hydroxypropyl-Beta-cyclodextrin for treatment of Niemann-Pick C disease1U01HD090845-01 | ORY, DANIEL S | WASHINGTON UNIVERSITY, MO | $529,267 | ZRG1 |
| 2017 | SINGLE-CELL TRANSCRIPTOMIC ANALYSIS OF HIV-INFECTED CD4 T CELLS IN BLOOD AND LYMPHOID TISSUE USING PCR-ACTIVATED CELL SORTING1U01AI129206-01 | ABATE, ADAM R.BORITZ, ELI A | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $481,092 | ZAI1 |
| 2017 | Optical and electromagnetic tracking guidance for hepatic interventions1U01CA202934-01A1 | MAHMOOD, UMAR | MASSACHUSETTS GENERAL HOSPITAL, MA | $421,989 | ZCA1 |
| 2017 | Bench to bedside: non-invasive treatment of tumors in children1U01CA202947-01A1 | KIM, PETER CWSHARMA, KARUN VWOOD, BRADFORD J | CHILDREN'S RESEARCH INSTITUTE, DC | $350,585 | ZCA1 |
| 2017 | Genetic Diagnosis of Childhood Growth Disorders1U01HD086838-01A1 | BARON, JEFFREYJEE, YOUN HEERADOVICK, SALLY | JOHNS HOPKINS UNIVERSITY, MD | $168,712 | ZRG1 |
| 2016 | The Molecular and Genetic Pathogensis of LAM1U01HL131022-01 · under PAR-13-358 | HENSKE, ELIZABETH P | BRIGHAM AND WOMEN'S HOSPITAL, MA | $754,946 | ZHL1 |
| 2016 | Developing a translational pipeline for NF1-mutant malignancies1U01CA202943-01 · under PAR-13-358 | CICHOWSKI, KAREN MWIDEMANN, BRIGITTE | BRIGHAM AND WOMEN'S HOSPITAL, MA | $578,917 | ZCA1 |
| 2016 | Underlying Mechanisms of Vascular Disease1U01HL131019-01 · under PAR-13-358 | BOEHM, MANFREDIRUELA-ARISPE, M. LUISA | UNIVERSITY OF CALIFORNIA LOS ANGELES, CA | $524,790 | ZHL1 |
| 2016 | Developing clinical, immunologic and radiographic tools to measure the clinical effect of immunotherapy in biochemically recurrent prostate cancer1U01CA202939-01 · under PAR-13-358 | GULLEY, JAMES L.KANTOFF, PHILIP W | SLOAN-KETTERING INST CAN RESEARCH, NY | $470,524 | ZCA1 |
| 2016 | Microbial, immune, metabolic perturbations by antibiotics (MIME study)1U01AI122285-01 · under PAR-13-358 | BLASER, MARTIN J | NEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY | $423,750 | ZAI1 |
| 2015 | Choroid Plexus-Directed Gene Therapy for Alpha-Mannosidosis1U01HD079066-01A1 · under PAR-13-358 | WOLFE, JOHN H | CHILDREN'S HOSP OF PHILADELPHIA, PA | $656,702 | ZRG1 |
| 2015 | Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant1U01AI115714-01 · under PAR-13-358 | MASUR, HENRYSTOCK, PETER G | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $601,291 | ZAI1 |
| 2015 | Phase II Study of AAV9-GAA Gene Transfer in Pompe Disease1U01HL121842-01A1 · under PAR-13-358 | BYRNE, BARRY J | UNIVERSITY OF FLORIDA, FL | $601,129 | ZHL1 |
| 2015 | Tesamorelin Effects on Liver Fat and Histology in HIV: A Collaborative U01 Grant1U01AI115711-01 · under PAR-13-358 | GRINSPOON, STEVEN K.HADIGAN, COLLEEN M | MASSACHUSETTS GENERAL HOSPITAL, MA | $587,655 | ZAI1 |
| 2015 | Beyond the reproductive tract: The future of Y chromosome research1U01HG007587-01A1 · under PAR-13-358 | MUENKE, MAXIMILIANPAGE, DAVID C. | WHITEHEAD INSTITUTE FOR BIOMEDICAL RES, MA | $487,619 | GNOM |
| 2015 | Cerebellar Structure and Function Studies in Very Early Abstinence1U01AA023674-01 · under PAR-13-358 | FEIN, GEORGE | NEUROBEHAVIORAL RESEARCH, INC., HI | $464,024 | ZRG1 |
| 2015 | Mucosal and Systemic Immune Responses to Influenza Virus1U01AI115715-01 · under PAR-13-358 | GREENBERG, HARRY BERNARD | PALO ALTO VETERANS INSTIT FOR RESEARCH, CA | $427,852 | ZAI1 |
| 2015 | PSMA Directed Imaging of Prostate Cancer Focus on Androgen Receptor Dynamics1U01CA183031-01A1 · under PAR-13-358 | DEWEESE, THEODORE LPOMPER, MARTIN G | JOHNS HOPKINS UNIVERSITY, MD | $410,209 | ZCA1 |
| 2015 | Antiretroviral Therapy in Aicardi Goutieres Syndrome1U01HD082806-01 · under PAR-13-358 | GAHL, WILLIAM ALLENVANDERVER, ADELINE LUCIE | CHILDREN'S RESEARCH INSTITUTE, DC | $288,019 | ZRG1 |
| 2015 | Single chain urokinase plasminogen activator (scuPA) for treatment of loculated complicated parapneumonic effusions and empyema1U01HL121841-01A1 · under PAR-13-358 | IDELL, STEVENMASUR, HENRYWOODS, CHRISTIAN J | UNIVERSITY OF TEXAS HLTH CTR AT TYLER, TX | $74,071 | ZHL1 |
| 2014 | MRI-safe 3Dl intracardiac ultrasound catheter for cardiovascular intervention1U01HL121838-01 · under PAR-13-029 | DEGERTEKIN, F. LEVENTLEDERMAN, ROBERT J | GEORGIA INSTITUTE OF TECHNOLOGY, GA | $683,344 | ZHL1 |
| 2014 | Therapeutic Elimination of Stem Cells for Relapsed Pediatric AML1U01CA183030-01 · under PAR-13-029 | LIU, YANGSCHORE, REUVEN J | CHILDREN'S RESEARCH INSTITUTE, DC | $653,666 | ZCA1 |
| 2014 | Stem Cell Gene Therapy Following R-EPOCH for Non-Hodgkin Lymphoma in AIDS Patient1U01CA183012-01 · under PAR-13-029 | ZAIA, JOHN A | BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA | $465,641 | ZCA1 |
| 2014 | Integrative molecular imaging and sequencing of prostate cancer1U01CA183027-01 · under PAR-13-029 | CHINNAIYAN, ARUL MLINEHAN, MARSTON | UNIVERSITY OF MICHIGAN AT ANN ARBOR, MI | $416,880 | ZCA1 |
| 2014 | Birth Defects: Moebius syndrome and related facial weakness disorders1U01HD079068-01 · under PAR-13-029 | BROOKS, BRIAN PATRICKENGLE, ELIZABETH C.JABS, ETHYLIN WANGMANOLI, IRINIPIERPAOLI, CARLO | ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY | $388,120 | ZRG1 |
| 2014 | A Phase 1 Dose Escalation Study of Vorinostat in Niemann-Pick C1 Disease1U01HD079065-01 · under PAR-13-029 | MAXFIELD, FREDERICK R.ORY, DANIEL S | WASHINGTON UNIVERSITY, MO | $360,223 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.